About Karyopharm
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.
Learn MorePipeline
Our Drug Candidates:
SINE Compounds and PAK4 Inhibitor
Stock Quote (KPTI)
Investor Information
Service temporary unavailable
9.170
0.000 (0%)
2019-02-19 16:00:00
Previous Close | 9.170 |
---|---|
Open | 0.000 |
Volume | 0 |
Exchange | NASDAQ |
Day High | 9.510 |
---|---|
Day Low | 8.790 |
52-Week High | 21.710 |
52-Week Low | 8.010 |
Publications
Scientific Papers, Posters and Presentations on Karyopharm pipeline compounds
Visit Archive